{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T22:14:59Z","timestamp":1758924899875},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.2174\/13816128113196660677","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T08:16:31Z","timestamp":1402647391000},"page":"3647-3656","source":"Crossref","is-referenced-by-count":2,"title":["Sodium-Glucose Co-Transporter 2 Inhibition in Diabetes Treatment: Current Evidence and Future Perspectives"],"prefix":"10.2174","volume":"20","author":[{"given":"Evangelos","family":"Rizos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses","family":"Elisaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/115301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T13:56:19Z","timestamp":1448027779000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1381-6128&volume=20&issue=22&spage=3647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":0,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/13816128113196660677","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}